Leaflet:information for the patient

Rosuvastatina/Ezetimiba pensa 20 mg/10 mg film-coated tablets

Read this leaflet carefully before you start taking this medicine,because it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• 1. If you have any questions, consult yourdoctor or pharmacist.

-This medicine has been prescribedonlyfor you, and you should not give it to others even if they havethe same symptomsas you, as it may harm them.

• If you experience any side effects,consult your doctor or pharmacist,evenif they are not listed in this leaflet. See section 4.

1.What is Rosuvastatina/Ezetimiba pensa and what it is used for

2.What you need to knowbeforestarting totake Rosuvastatina/Ezetimiba pensa

3.How to take Rosuvastatina/Ezetimiba pensa

4.Possible side effects

5Storage of Rosuvastatina/Ezetimiba pensa

6.Contents of the pack and additional information

Rosuvastatina/Ezetimiba pensa contains two different active principles in a coated tablet. One of the active principles is rosuvastatina, which belongs to the group of statins, the other active principle is ezetimiba.

Rosuvastatina/Ezetimiba is a medication used to reduce the concentrations of total cholesterol, "bad" cholesterol (LDL cholesterol) and certain fatty substances called triglycerides that circulate in the blood. In addition, Rosuvastatina/Ezetimiba increases the concentrations of "good" cholesterol (HDL cholesterol). This medication acts by reducing cholesterol in two ways: reducing the cholesterol absorbed in the digestive tract, as well as the cholesterol produced by the body itself.

For most people, high levels of cholesterol do not affect how they feel since they do not produce any symptoms. However, if left untreated, fatty deposits can accumulate in the walls of blood vessels and narrow them. Sometimes, these narrowed blood vessels can become blocked, cutting off blood supply to the heart or brain, which would cause a heart attack or cerebral embolism. By reducing cholesterol levels, the risk of having a heart attack, cerebral embolism, or other related health problems can be reduced.

This medication is used in patients who cannot control their cholesterol levels solely with diet. While taking this medication, you must follow a cholesterol-reducing diet. Your doctor may prescribe Rosuvastatina/Ezetimiba if you are already taking rosuvastatina and ezetimiba at the same dose level.

This medication is used in patients with heart disease. Rosuvastatina/Ezetimiba reduces the risk of myocardial infarction, cerebral accident, heart surgery to increase blood flow to the heart, or hospitalization for chest pain.

Rosuvastatina/Ezetimiba does not help you lose weight.

Do not takeRosuvastatina/Ezetimiba if:

• You are allergic to rosuvastatina, ezetimiba, or any of the other components of this medication (listed in section 6),
• You have liver disease,
• You have severe kidney problems,
• You have repeated or unjustified muscle pain and cramps (myopathy),
• You are taking a combination of sofosbuvir/velpatasvir/voxilaprevir (medications used to treat a viral liver infection called hepatitis C),
• You are taking a medication called ciclosporina (used, for example, after an organ transplant),
• You are pregnant or breastfeeding. If you become pregnant while taking rosuvastatina/ezetimiba, stop taking it immediately and inform your doctor. Women should avoid becoming pregnant during treatment with rosuvastatina/ezetimiba using an appropriate contraceptive method.
• You have ever developed a severe skin rash or skin peeling, blisters, and/or mouth sores after taking rosuvastatina/ezetimiba or another medication containing rosuvastatina.

If you find yourself in any of the above situations (or are unsure), consult your doctor.

Warnings and precautions

Consult your doctor or pharmacist before starting to take this medication if:

• You have kidney problems,
• You have liver problems,

• You have repeated or unjustified muscle pain and cramps, a personal or family history of muscle problems, or a previous history of muscle problems during treatment with other medications to lower cholesterol. Inform your doctor immediately if you have unjustified muscle pain or cramps, especially if you have general discomfort or fever. Also, inform your doctor or pharmacist if you have constant muscle weakness,
• You have or have had myasthenia (a disease that causes generalized muscle weakness, which in some cases affects the muscles used for breathing) or myasthenia gravis (a disease that causes weakness of the eye muscles), as statins may sometimes worsen the disease or cause myasthenia (see section 4),
• You are of Asian origin (for example, Japanese, Chinese, Filipino, Vietnamese, Korean, or Indian). Your doctor should establish the appropriate dose for you,
• You are taking medications to treat infections, including HIV (HIV virus) or hepatitis C, such as ritonavir with lopinavir and/or atazanavir. See “Other medications and Rosuvastatina/Ezetimiba pensa”,
• You have severe respiratory failure,
• You are taking other medications called fibrates to lower cholesterol, see “Other medications and Rosuvastatina/Ezetimiba pensa”,
• You regularly consume large amounts of alcohol,
• Your thyroid gland does not function correctly (hypothyroidism),
• You are over 70 years old, (as your doctor should choose the appropriate dose of rosuvastatina/ezetimiba for you).
• You are taking or have taken within the last 7 days a medication called fusidic acid (an antibacterial medication) orally or injectable. The combination of fusidic acid and rosuvastatina/ezetimiba may cause severe muscle problems (rhabdomyolysis).

If you find yourself in any of these situations mentioned above (or are unsure): consult your doctor or pharmacist before starting to take any dose of rosuvastatina/ezetimiba.

Severe skin reactions, including Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported associated with rosuvastatina treatment.Stop taking rosuvastatina/ezetimiba and seek medical attention immediatelyif you notice any of the symptoms described in section 4.

In a small number of people, statins can affect the liver. This is detected by a simple test that detects increased levels of liver enzymes (transaminases) in the blood. For this reason, your doctor will usually perform blood tests (liver function test) during treatment with rosuvastatina/ezetimiba. It is essential that you visit your doctor for the tests.

While taking this medication, your doctor will closely monitor you if you have diabetes or are at risk of developing diabetes. You may be at risk of developing diabetes if you have high blood sugar and fat levels, are overweight, and have high blood pressure.

Children and adolescents

Rosuvastatina/ezetimiba is not recommended for use in children and adolescents under 18 years of age.

Other medications andRosuvastatina/Ezetimiba pensa

Inform your doctor or pharmacist if you aretaking, havetakenrecentlyor may have to takeany other medication.

Inform your doctor if you are taking any of the following medications:

• Ciclosporina (used after an organ transplant to prevent organ rejection. The effect of rosuvastatina is increased with its use together).Do not take rosuvastatina/ezetimiba if you are taking ciclosporina.
• Anticoagulants, such as warfarin, acenocoumarol, or fluindione (their anticoagulant effects and the risk of bleeding may increase while taking rosuvastatina/ezetimiba together), ticagrelor, or clopidogrel.
• Other medications to lower cholesterol called fibrates, which also correct triglyceride levels in the blood (e.g., gemfibrozil and other fibrates). The effect of rosuvastatina is increased with its use together.
• Colestiramina (a medication also used to lower cholesterol), because it affects how ezetimiba works.
• Regorafenib (used to treat cancer).
• Simeprevir (used to treat chronic hepatitis C)

• Darolutamida (used to treat cancer).
• Any of the following medications used to treat viral infections, including HIV or hepatitis C, alone or in combination (see Warnings and Precautions): ritonavir, lopinavir, atazanavir, sofosbuvir, voxilaprevir, ombitasvir, paritaprevir, dasabuvir, velpatasvir, grazoprevir, elbasvir, glecaprevir, pibrentasvir.
• Treatments for indigestion containing aluminum and magnesium (used to neutralize stomach acid, as they reduce the level of rosuvastatina in plasma). This effect can be mitigated by taking this type of medication 2 hours after rosuvastatina.
• Eritromicina (an antibiotic). The effect of rosuvastatina is decreased with its use together.
• Fusidic acid. If you need to take fusidic acid orally to treat a bacterial infection, you should temporarily stop taking this medication. Your doctor will indicate when you can safely take rosuvastatina/ezetimiba again. Taking rosuvastatina/ezetimiba with fusidic acid may occasionally cause muscle weakness, pain, or sensitivity (rhabdomyolysis). You can consult more information about rhabdomyolysis in section 4.
• Oral contraceptive (the pill). The levels of sex hormones absorbed from the pill are increased.
• Capmatinib (used to treat cancer).
• Hormone replacement therapy (increased levels of hormones in the blood).
• Fostamatinib (used to treat low platelet count).
• Febuxostat (used to treat and prevent high uric acid levels in the blood).
• Teriflunomida (used to treat multiple sclerosis)

If you visit a hospital or receive treatment for another condition, inform the medical staff that you are taking rosuvastatina/ezetimiba.

Pregnancy andlactation

If you are pregnant or breastfeeding, consult your doctor or pharmacist before using this medication. If you become pregnant while taking rosuvastatina/ezetimiba, stop taking it immediately and inform your doctor. Women should use contraceptive methods during treatment with rosuvastatina/ezetimiba.

Do not take rosuvastatina/ezetimiba if you are breastfeeding, as it is unknown whether the medication passes into breast milk.

Driving and operating machinery

Rosuvastatina/ezetimiba is not believed to interfere with your ability to drive or operate machinery. However, some people may feel dizzy during treatment with rosuvastatina/ezetimiba. If you feel dizzy, consult your doctor before attempting to drive or operate machinery.

Rosuvastatina/Ezetimiba pensa contains lactose

This medication contains lactose. If your doctor has indicated that you have an intolerance to certain sugars, consult with them before taking this medication.

Rosuvastatina/Ezetimiba pensa contains sodium

This medication contains less than 1 mmol of sodium (23 mg) per coated tablet; it is essentially “sodium-free”.

Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

You must continue to maintain a low-cholesterol diet and exercise while taking rosuvastatina/ezetimiba.

The recommended daily dose for adults is one film-coated tablet of the concentration in question.

Take Rosuvastatina/Ezetimiba once a day.

You can take it at any time of the day with or without food. Swallow each tablet whole with water. Try to take the tablet at the same time every day.

Rosuvastatina/Ezetimiba is not suitable for starting treatment. The initiation of treatment or dose adjustments, if necessary, should only be made by taking the active ingredients separately, and once the appropriate doses have been adjusted, it is possible to switch to rosuvastatina/ezetimiba at the corresponding dose.

Regular cholesterol level checks

It is essential that you visit your doctor regularly for cholesterol checks, in order to verify that your cholesterol levels have normalized and are maintained at appropriate levels.

If you take more Rosuvastatina/Ezetimiba pensa than you should

Contact your doctor or the emergency department of the nearest hospital as you may require medical assistance.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

If you forget to take Rosuvastatina/Ezetimiba pensa

Do not worry, simply take the next scheduled dose at the scheduled time. Do not take a double dose to compensate for the missed doses.

If you interrupt treatment with Rosuvastatina/Ezetimiba pensa

Consult your doctor if you want to discontinue treatment with rosuvastatina/ezetimiba. Your cholesterol levels may increase again if you stop taking rosuvastatina/ezetimiba.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Like all medicines, this medicine can cause side effects, although not everyone will experience them.

It is important that you know which side effects may occur.

Stop taking this medicine and seek medical attention immediately if you notice any of the following symptoms:

Rare side effects (may affect up to 1 in 1,000 people):

• Allergic reactions such as swelling of the face, lips, tongue, and/or throat, which may cause difficulty breathing and swallowing.
• Unjustified muscle aches and cramps that last longer than expected. In rare cases, this can become a potentially fatal muscle damage known as rhabdomyolysis, leading to general discomfort, fever, and kidney failure.
• Lupus-like syndrome (including rash, joint disorder, and effects on blood cells).
• Muscle rupture.

Side effects of unknown frequency (cannot be estimated from available data):

• Reddish patches on the trunk in the shape of a target or circles, often with central blisters, skin peeling, mouth ulcers, throat, nose, genital, and eye ulcers. These severe skin eruptions may be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome).
• Generalized rash, elevated body temperature, and swollen lymph nodes (DRESS or drug hypersensitivity syndrome).
• Erythema multiforme (potentially fatal allergic reactions affecting the skin and mucous membranes).

Other possible side effects:

Frequent (may affect up to 1 in 10 people):

• Headache;
• Constipation;
• General discomfort;
• Muscle pain;
• Weakness;
• Dizziness;
• Diabetes. This is more likely if you have high blood sugar and lipid levels, being overweight, and high blood pressure. Your doctor will monitor you while taking this medicine.
• Abdominal pain (stomach pain);
• Diarrhea;
• Flatulence (excess gas in the intestinal tract);
• Feeling tired;
• High levels in some blood test results for liver function (transaminases).

Occasional (may affect up to 1 in 100 people):

• Skin rash, itching, urticaria;
• Increased protein levels in urine, which usually returns to normal on its own without the need to discontinue treatment with rosuvastatin;
• High levels in some blood test results for muscle function (CK);
• Cough;
• Indigestion;
• Heartburn;
• Joint pain;
• Muscle spasms;
• Neck pain;
• Loss of appetite;
• Pain;
• Chest pain;
• Hot flashes;
• High blood pressure;
• Tickling sensation;
• Dry mouth;
• Stomach inflammation;
• Back pain;
• Muscle weakness;
• Pain in the arms and legs;
• Swelling, especially in the hands and feet.

Rare (may affect up to 1 in 1,000 people):

• Pancreatitis, which causes severe stomach pain that may extend to the back;
• Reduction in platelet levels.

Very rare (may affect up to 1 in 10,000 people):

• Icterus (yellowing of the skin and eyes);
• Hepatitis (inflammation of the liver);
• Traces of blood in the urine;
• Nerve damage in the legs and arms (such as numbness);
• Memory loss;
• Enlargement of the breasts in men (gynecomastia).

Unknown frequency (cannot be estimated from available data):

• Difficulty breathing;
• Edema (swelling);
• Sleep disturbances, including insomnia and nightmares;
• Sexual dysfunction;
• Depression;

• Respiratory problems, including persistent cough and/or difficulty breathing or fever;
• Tendon damage;
• Constant muscle weakness;
• Calculi in the gallbladder or inflammation of the gallbladder (which may cause abdominal pain, nausea, vomiting);
• Myasthenia gravis (a disease that causes generalized muscle weakness, which in some cases affects the muscles used for breathing);
• Myasthenia ocular (a disease that causes weakness of the eye muscles)

Consult your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing.

Reporting side effects

If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSpanish System for Pharmacovigilance of Medicines for Human Use:www.notificaRAM.es.

By reporting side effects, you can contribute to providing more information on the safety of this medicine.

Keep this medication out of the sight and reach of children.

This medication does not require any special temperature for conservation..

Store in the original packaging to protect it from light and moisture.

Do not use this medication after the expiration date that appears on the box and on the blister pack after “CAD”. The expiration date is the last day of the month indicated.

Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.

Composition of Rosuvastatina/Ezetimiba pensa

The active principles are rosuvastatina (as rosuvastatina calcium) and ezetimiba. Each film-coated tablet contains 20 mg of rosuvastatina (as rosuvastatina calcium) and 10 mg of ezetimiba.

The other components (excipients) are:

Core of the tablet :Microcrystalline cellulose; Anhydrous colloidal silica; Magnesium stearate; Povidone; Sodium croscarmellose; Sodium lauryl sulfate; Monohydrate lactose; Hypromellose.

Coating material:

Hypromellose; Titanium dioxide; Macrogol; Yellow iron oxide (E-172); Talc.

Appearance of the product and content of the container

Rosuvastatina/Ezetimiba pensa 20 mg/10 mg film-coated tablets are yellow, round, biconvex, approximately 10 mm in diameter, and marked with the inscription “EL 3” on one face.

Rosuvastatina/Ezetimiba pensa is presented in carton boxes with blisters (OPA/Al/PVC/Al) of 30 film-coated tablets.

Holder of the marketing authorization and responsible for manufacturing

Holder of the marketing authorization

Towa Pharmaceutical, S.A.

C/ de Sant Martí, 75-97

08107 Martorelles (Barcelona)

Spain

Responsible for manufacturing

Elpen Pharmaceutical Co.Inc.

Marathonos 95

190 09 Pikermi, Attiki

Greece

O

Rontis Hellas Medical and Pharmaceutical Products S.A.

P.O Box 3012 Larissa Industrial Area,

Larissa, 41500

Greece

Last review date of thisleaflet: August 2024

The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)